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Introduction. Sepsis and its consequences such as metabolic acidosis are resulting in increased mortality. Although correction of
metabolic acidosis with sodiumbicarbonate seems a reasonable approach, there is ongoing debate regarding the role of bicarbonates
as a therapeutic option.Methods. We conducted a PubMed literature search in order to identify published literature related to the
effects of sodium bicarbonate treatment on metabolic acidosis due to sepsis. The search included all articles published in English
in the last 35 years. Results. There is ongoing debate regarding the use of bicarbonates for the treatment of acidosis in sepsis, but
there is a trend towards not using bicarbonate in sepsis patients with arterial blood gas pH > 7.15. Conclusions. Routine use of
bicarbonate for treatment of severe acidemia and lactic acidosis due to sepsis is subject of controversy, and current opinion does
not favor routine use of bicarbonates. However, available evidence is inconclusive, and more studies are required to determine the
potential benefit, if any, of bicarbonate therapy in the sepsis patient with acidosis.
1. Introduction
Sepsis and septic shock constitute an important cause of
morbidity andmortality in the critically ill patient. Metabolic
acidosis, including lactic acidosis, is part of the underlying
pathophysiology in sepsis and is related to poor prognosis.
The treatment of metabolic acidosis is based on control
of the underlying pathophysiologic process and reversal
of organ dysfunction. Etiologic treatment is essential in
metabolic acidosis, but optimization of oxygen delivery to
tissues and reduction of tissue oxygen demand through
sedation and mechanical ventilation are parts of the ther-
apeutic strategy. Severe acidemia in sepsis contributes to
hemodynamic instability, which is the result of reduced
myocardial contractility, arterial vasodilation, and impaired
responsiveness to catecholamines. As the effect of alkaline
therapy on vasopressor requirements and hemodynamic
profile in severe acidosis (pH ≤ 7.15) is unknown, current
Surviving Sepsis Campaign guidelines recommend against
treatment with bicarbonates. Despite lack of data on the
effect of bicarbonate therapy, many intensivists attempt to
alkalinize blood with intravenous administration of sodium
bicarbonate as part of the treatment of sepsis. However, the
benefit of bicarbonate administration in metabolic acidosis
in sepsis is controversial and remains a matter of debate in
clinical practice.
The aim of this review is to evaluate and summarize the
published literature regarding the indications and benefits of
sodium bicarbonate administration in septic patients with
metabolic acidosis.
2. Methods
We conducted a literature search in the MEDLINE database
(January 1980 to March 2015), using the combination of
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the terms “sepsis,” “metabolic acidosis,” and “bicarbonates.”
The literature search included all type of articles, and the
bibliography from all relevant extracted manuscripts was
reviewed for identification of additional related references.
All identified manuscripts, including reviews, case series,
and case reports, were evaluated for relevance, and articles
deemed pertinent, current, and representative were included
in this review. Publications in languages other than English
and without abstract in English were excluded. Two authors
evaluated the abstracts of all identified articles (DV and
MK) and the full text of letters and case reports. Differ-
ences of opinion were resolved by reaching consensus after
discussion.
3. Results
The PubMed literature search was conducted in March 2015
and yielded 51 publications.
A prospective, randomized, blinded, crossover study
published in 1990 by Cooper et al. assessed bicarbonate
administration on 14 intensive care unit (ICU) patients with
metabolic acidosis and increased arterial lactate. In this
study, each patient received sodium bicarbonate (2mmol/kg
infused over 15 minutes) and equimolar sodium chloride
sequentially, in random order. After sodium bicarbonate





) increased, while plasma
ionized calcium decreased. Both sodium bicarbonate and
sodium chloride transiently increased pulmonary capillary
wedge pressure and cardiac output, butmean arterial pressure
did not change and hemodynamic responses to sodiumbicar-
bonate and sodium chloride were the same. This study con-
cluded that the hemodynamic and cardiovascular response
to catecholamines did not improve with sodium bicarbonate
administration [1].
Another prospective, randomized, blinded, crossover
study published byMathieu et al. in 1991 assessed bicarbonate
administration (1mmol/kg) for correction of acidemia in ten
patients with lactic acidosis, by measuring hemodynamic
variables and evaluating tissue oxygenation. Each patient
received sequentially sodium bicarbonate and sodium chlo-
ride in random order. Sodium bicarbonate administration
resulted in increased arterial and venous blood pH, but
hemodynamic variables did not improve, and tissue oxygena-
tion, as measured by oxygen delivery, oxygen consumption,
oxygen extraction, and transcutaneous oxygen pressure, did
not change. The study concluded that sodium bicarbonate
did not significantly change hemodynamic profile or worsen
tissue oxygenation [2].
Another prospective clinical trial published in 2008 by
Fang et al. assessed the effects of resuscitationwith 5mL/kg of
three different solutions (normal saline versus sodium chlo-
ride 3.5% versus sodium bicarbonate 5%) on cardiac function
in 94 patients with severe sepsis and showed that although
mean arterial pressure and cardiac output improved faster
in the sodium bicarbonate group, there was no significant
difference between the three groups with regard to pH, lactic
acid, cardiac output, heart rate, or 28-day mortality [3].
A prospective, observational study by Noritomi et al.
in 2009 in ICU patients showed that acidosis in survivors
was corrected as a result of decreased lactate and strong ion
gap levels, whereas metabolic acidosis did not improve in
nonsurvivors [4]. A retrospective study published in 2010 by
El-Solh et al. compared 36 patients with septic shock versus
a group of 36 patients matched for age, site of infection,
and predicted mortality who did not receive bicarbonate
therapy and showed that duration of the need for mechanical
ventilation and ICU length of stay were reduced in patients
who received bicarbonates, but themedian time until reversal
of shock and 28-day mortality did not differ between groups
[5].
Similarly, a prospective, multicenter observational study
on 200 patients with severe acidemia (pH < 7.20) from 5
ICUs in France showed that bicarbonate use varied between
5% and 55% of patients between institutions, bicarbonate
administration depended on the medical center, rather than
the mechanism of acidemia, and there was no association
between bicarbonate administration and outcome [6].
Another retrospective analysis by Kim et al. in 2013
analyzed 103 patients with lactic acidosis of multiple causes,
including sepsis. Multivariate logistic regression showed that
SOFA score and sodium bicarbonate administration were
independent factors associated with higher mortality [7].
According to this study, lactic acid levels should be checked
to evaluate the course of metabolic acidosis in sepsis patients,
particularly thosewith high anion gap, as there is concern that
bicarbonates could increase mortality.
A prospective randomized, double-blind, controlled clin-
ical trial by Chen et al. in 2013 assessed the use of sodium
bicarbonate in two stages for treatment of lactic acidemia
due to hypoperfusion in 65 critically ill patients with septic
shock and concluded that bicarbonate therapy significantly
improved cardiac index, oxygen delivery, and mixed venous
oxygen saturation and resulted in lower incidence of multiple
organ dysfunction, shorter duration of mechanical ventila-
tion, shorter ICU and hospital stay, and lower mortality [8].
Of note, the study by Chen et al. was published in Chinese but
comes with a very detailed abstract in English, and we chose
to include it in our review because its findings are markedly
different compared to most other published clinical studies
on the subject. Data from clinical studies evaluating the use
of sodium bicarbonate in sepsis patients with acidosis are
summarized in Table 1.
A survey published by Kraut and Kurtz in 2006 clearly
shows the uncertainty among clinicians as to whether or
not bicarbonates should be given to patients with metabolic
acidosis. In this survey, 86% of nephrologists would give
bicarbonate for treatment of lactic acidosis, compared to only
67% of intensivists. The authors concluded that the observed
variability between physicians shows the need for further
studies in order to generate data that could support evidence-
based guidelines [9].
With regard to reviews, opinion articles, and guidelines,
Levraut andGrimaud in 2003 reported a theoretical approach
to metabolic acidosis, which should be differentiated to
“mineral metabolic acidosis” or “organic metabolic acido-
sis.” The authors concluded that “mineral acidosis” is not
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Table 1: Clinical studies evaluating bicarbonate use in sepsis patients with acidosis. Studies are listed in chronological order, based on year
of publication.
Reference Country, year Study design Results
Cooper et al. [1] British Columbia,Canada, 1990
Prospective, randomized,
blinded, crossover study, 14
patients
Sodium bicarbonate did not improve
hemodynamics or the response to catecholamines
and caused hypocalcemia and hypercarbia
Mathieu et al. [2] Lille, France, 1991
Prospective, randomized,
blinded, crossover study, 10
patients
Sodium bicarbonate increased arterial and venous
pH, serum bicarbonate, and arterial and venous
blood pCO
2
, but hemodynamic responses similar
to sodium chloride
Fang et al. [3] Nanjing, China,2008
Prospective, randomized trial, 94
patients
5% sodium bicarbonate for resuscitation in severe
sepsis with hypotension improved blood pressure
and cardiac output earlier than saline or
hypertonic sodium chloride, indicating limited
benefit from bicarbonate in sepsis
Noritomi et al. [4] Sao Paulo, Brazil,2009
Prospective, observational study,
60 ICU patients with severe
sepsis or septic shock
Lactate reduced and metabolic acidosis corrected
in survivors, but not in nonsurvivors
El-Sholh et al. [5] New York, USA,2010
Retrospective study, 36 patients
with septic shock who received
bicarbonates versus 36 matched
patients who did not
Bicarbonate group had shorter duration of
mechanical ventilation but no difference in 28-day
mortality
Jung et al. [6] Montpellier,France, 2011
Prospective multicenter
observational study, 200 patients
with severe acidosis
Bicarbonate administration in 5–55% of patients,
depending on center, not on acidosis mechanism.
No association between bicarbonate and outcome
Chen et al. [8] Jiangsu, China,2013
Prospective, randomized trial, 65
patients
Patients who received bicarbonate had improved
hemodynamics, shorter mechanical ventilation,
shorter ICU and hospital stay, and lower mortality
Kim et al. [7] Busan, Korea,2013
Retrospective study, 103 patients
with lactic acidosis
Bicarbonate use was independent risk factor for
increased mortality
related to failure of energy metabolic pathways and could
be treated with bicarbonate administration to improve pH,
whereas “organic acidosis” is evidence of severe underlying
metabolic distress, and management is based on addressing
the cause of acidosis, rather than correction of the acid-
base imbalance [10]. Similarly, a 2004 publication by Cariou
et al. summarized the recommendations presented in 2003
based on experts’ opinion from 11 international organizations
under the auspices of the Surviving Sepsis Campaign. These
guidelines do not recommend bicarbonate administration
as therapeutic option to improve hemodynamic status or
reduce vasopressor requirements in sepsis patients with lactic
acidosis and pH > 7.15 [11]. Similarly, a review article by
Boyd and Walley in 2008 agreed with the Surviving Sepsis
guidelines, recommended against bicarbonate use for pH >
7.15, and went even further, recommending a lower threshold
for treatment at pH ≤ 7.0. These authors also suggested that
bicarbonate-based replacement fluid is preferred to citrate
infusion for continuous renal replacement therapy [12]. Last,
the Surviving Sepsis Campaign guidelines in 2010 proposed a
grade 2B recommendation for not using sodium bicarbonate
therapy in sepsis patients for the purpose of improving
hemodynamic status or reducing vasopressor requirements
in hypoperfusion-induced lactic acidemia with pH≥ 7.15 [13].
With regard to experimental data, dog experiments
conducted in the 1970s suggest that plasma bicarbonate
concentration influences the apparent volume of distribution
of bicarbonate so that when bicarbonate is administered, the
proportion of bicarbonate passing into the intracellular space
increases with decreasing bicarbonate concentration [14]. A
study by Valenza et al. in 2012 in normoxic, normotensive
rats showed that pH decreased with infusion of lactic acid
and rose with bicarbonate administration, but the effect of
bicarbonate infusion on pH was different with persistent
versus transient acid load [15]. An earlier study by Arieff et
al. showed that bicarbonate administration did not improve
hemodynamic parameters or reduce mortality in an animal
model of lactic acidosis [16]. However, an experimental study
by Benjamin et al. on dogs subjected to hemorrhagic shock
showed that bicarbonate administration resulted inmoderate
increase of blood pressure, cardiac index, oxygen delivery
index, and oxygen consumption index, but this benefit was
not better compared to administration of hypertonic saline
[17]. Other in vitro experiments performed by Goldsmith et
al. in 1997 measured intracellular pH changes in leucocytes
from healthy volunteers using a fluorescent intracellular dye
and described deleterious effects after alkalinization of the
extracellular fluid by giving sodium bicarbonate [18]. In
addition, an in vitro study on humanhepatocytes showed that
bicarbonate administration can decrease intracellular pH,
and the change in intracellular pH depends on pCO
2
changes
in the fluid surrounding the cells [19]. However, a newer
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Table 2: Laboratory studies evaluating bicarbonate administration in sepsis or acidosis. Studies are listed in chronological order, based on
year of publication.
Reference Country, year Study design Results
Garella et al. [14] Providence, RI,USA, 1973
156 dogs, low, normal, or high
bicarbonate concentration
Preexisting plasma bicarbonate concentration
influences the apparent bicarbonate volume of
distribution
Arieff et al. [16] San Francisco,USA, 1982
Dogs with phenformin-induced
lactic acidosis
Bicarbonate reduced portal vein blood flow,
cardiac output, and pH in liver and erythrocytes
Benjamin et al. [17] New York, USA,1994
Experimental hemorrhagic shock
in dogs, compared bicarbonate
versus hypertonic saline versus
Carbicarb
Bicarbonate moderately increased blood pressure,
cardiac index, oxygen delivery, and oxygen
consumption but not better than hypertonic saline
Goldsmith et al. [18] London, UK, 1997 Human leukocytes in vitro Sodium bicarbonate caused intracellularacidification
Levraut et al. [19] Nice, France, 2001 Human hepatocytes in vitro
Sodium bicarbonate decreases intracellular pH,
and intracellular pH changes are linked to pCO
2
in surrounding fluid
Nielsen et al. [20] Copenhagen,Denmark, 2002
31P-magnetic resonance
spectroscopy in skeletal muscle
of healthy subjects
Bicarbonate administration attenuated the
reduction of intracellular muscle pH
Valenza et al. [15] Milan, Italy, 2012 32 Sprague Dawley rats in fourgroups
Bicarbonate corrected acidosis in normoxic,
normotensive rats, but effects of bicarbonate on
pH different in rats receiving transient versus
persistent lactic acid infusion
study from Denmark evaluated intracellular pH of muscle
tissue in healthy volunteers and showed that bicarbonate
administration attenuated the reduction of intracellular pH
induced by exercise [20]. Experimental data related to the
use of bicarbonates in sepsis or acidosis are summarized in
Table 2.
4. Discussion
Sepsis is a serious, potentially fatal disease commonly seen
in intensive care units all over the world. Mortality rate
is high (36.7%) in sepsis patients with hypotension only
or with elevated lactate ≥ 4mmol/L only (30%) but is
even higher (46.1%) in patients with both hypotension
and lactate ≥ 4mmol/L. Metabolic acidosis is considered
a sign of severity of the underlying disease process, and
identification of the cause of acidosis is essential in order
to initiate timely appropriate therapy. Causes of metabolic
acidosis include sepsis, cardiogenic shock, severe hypoxemia,
hepatic failure, and intoxication. Most of these conditions
share similar pathogenic mechanisms, including reduced
oxygen delivery to cells and impaired oxygen consumption
in cell mitochondria, yet some conditions are due to more
complex derangements. Lactic acidosis in sepsis is a complex
process and the associated severe acidemia has important
clinical consequences, including hemodynamic instability
due to reduced left ventricular contractility, diastolic dysfunc-
tion and right ventricular failure, predisposition to cardiac
arrhythmias, arterial vasodilation, impaired responsiveness
to catecholamines, reduced hepatic blood flow, and impaired
oxygen tissue delivery. Metabolic effects of acidosis include
reduction of ATP synthesis in the cells, increased ionized
calcium levels, and insulin resistance. In severe acidemia
(blood pH < 7.1) these effects can result in organ dysfunction
and contribute to increased morbidity and mortality. Treat-
ment of lactic acidosis includes recognition and correction
of the underlying cause, provision of adequate oxygen tissue
delivery, and reduction of oxygen tissue demand through
sedation and mechanical ventilation. In addition, although
not recommended by published guidelines, ICU clinicians
sometimes attempt to increase blood pH with adminis-
tration of intravenous (IV) sodium bicarbonate. However,
persistence of lactic acidosis despite appropriate therapy is
associated with very high (up to 90%) mortality [21–24].
Metabolic acidosis can be the result of either a primary
increase in hydrogen ion (H+) or reduction of bicarbonate
concentration. In acute states of metabolic acidosis, respira-
tory compensation through hyperventilation results in rela-
tive reduction of PaCO
2
, whereas in chronic states the human
body develops renal compensation through reabsorption of
HCO
3
. The etiology of metabolic acidosis is divided into
causes resulting in elevated anion gap (AG) and causes that
do not. Lactic acidosis is a common cause of high anion
gap metabolic acidosis [9, 25–27] and is classified as type A
(anaerobic), which is associated with tissue hypoperfusion
and denotes a condition of intact mitochondrial function
but inadequate oxygen delivery (such as in shock states),
or type B (aerobic), wherein oxygen supply is adequate and
there is no tissue hypoxia, but acidosis is due to abnormal
carbohydrate metabolism, such as in hepatic failure, dia-
betes, or phenformin intoxication [28, 29]. In patients with
severe sepsis and septic shock, tissue hypoxia occurs due to
reduction of oxygen delivery to peripheral tissues [30], while
other mechanisms, including reduction of lactate clearance,
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reduced activation of the pyruvate dehydrogenase complex,
and alterations of mitochondrial function contribute to this
process.
Normal blood lactate levels in healthy humans are 0.5–
1mmol/L, but “normal” lactate concentrations in patients
with critical illness are <2mmol/L. Hyperlactatemia is
defined as mild to moderate when persistent increase in
blood lactate concentration (2–4mmol/L) without metabolic
acidosis exists, whereas lactic acidosis is characterized by
persistently increased blood lactate levels (>4-5mmol/L) in
association with metabolic acidosis. Acidosis can inhibit
lactic acid production by reducing activity of the enzyme
phosphofructokinase; therefore correction of metabolic aci-
dosis with sodium bicarbonate may increase lactic acid
production by inhibiting this compensatory response [31–
34].
Bicarbonate is the main form of CO
2
in the human body
and can be estimated from pH and pCO
2
. Normal pH range
is 7.35–7.45 and normal bicarbonate is 21–28mEq/L. Blood
pH is reduced (acidosis) when CO
2
quantity is elevated
and increases (alkalosis) when CO
2
quantity is reduced or
when the quantity of base, such as bicarbonate (HCO3
−),
increases in blood. Bicarbonate is secreted and absorbed
again (conservation) from the kidneys in response to pH
changes and is commonly encountered as sodium bicar-
bonate (NaHCO
3
). Bicarbonate administration can stimulate
superoxide formation, increase proinflammatory cytokine
release, and enhance apoptosis and may also result in para-
doxic intracellular acidosis due to generation of CO
2
. In
clinical use, bicarbonate administration in severe academia
may cause volume expansion and hypernatremia but can
also result in reduced blood pressure and cardiac output and
increased mortality.
If bicarbonate is to be used, it should be administered as
slow infusion, and the amount ofCO
2
that is produced should
be monitored. In patients with sepsis and severe acidosis
undergoing renal replacement therapy, use of bicarbonate-
based replacement fluids is recommended. Similarly, chronic
bicarbonate replacement is indicated in patients with renal
tubular acidosis.
Worldwide,many intensive care clinicians consider bicar-
bonate therapy as major component in the treatment of
sepsis in patients with metabolic acidosis [35] and in sepsis
patients with pH < 7.20, or, even more so, in patients with
pH < 7.0.This therapeutic approach is supported by evidence
suggesting that acute acidemia has deleterious effects on
organ function. However, although acidemia correction with
administration of bicarbonates aims to normalize extracellu-
lar and intracellular pH and improve outcome [11], several
studies suggest that this approach is overly simplistic [36]
and the impact of bicarbonate administration on restor-
ing hemodynamics, reducing vasopressor requirements, and
improving clinical outcomes is unknown [21]. In 2000, a
comment published in “Chest” by Cuhaci in response to an
earlier study by Forsythe and Schmidt [36] criticized the
suggestion to not routinely use bicarbonates in lactic acidosis
and questioned whether rejection of a reasonable therapeutic
option is wise, when this option does not cause harm and
there are no proven alternative options [37]. This comment
likely reflects clinical practice, as evidenced by a survey pub-
lished in 2006, which showed that 67% of 48 intensivists who
responded to the surveywould give bicarbonate for treatment
of lactic acidosis [9]. However, the argument that bicarbonate
administration does not cause harm is contradicted by the
“surviving sepsis guidelines” which state that “Bicarbonate
administration has been associated with sodium and fluid
overload, an increase in lactate and PCO
2
, and a decrease in
serum ionized calcium. . .” [21].
The appropriate treatment of metabolic acidosis, espe-
cially organic acidosis (such as lactic acidosis), is controver-
sial, but reduction of acid production via improved oxygen
tissue delivery is generally considered the most effective
treatment. Aggressive therapy of sepsis is based on appro-
priate antibiotics and on addressing the causes of acidosis,
with fluid resuscitation and restoration of cardiac function.
Goals of resuscitation in sepsis with severemetabolic acidosis
include maintenance of CVP > 8mmHg, ScvO
2
> 70% and
normalization of lactate, while bicarbonate administration
remains controversial [5].
Reasons for the absence of clear benefit from bicarbonate
administration include exacerbation of intracellular acidosis
due to initial rapid influx of CO
2
, loss of protective effects
provided by acidosis against hypoxic damage, the fact that
more calcium will bind to albumin instead of H+ leading to
reduction of ionized calcium which, in turn, decreases car-
diac output, and cellular swelling and dysfunction resulting
from acceleration of cellular influx of sodium and calcium in
response to worsening intracellular acidosis.
Additional risks of sodium bicarbonate administration
include increased plasma PaCO
2
, hyperosmolality, hyperna-
tremia, volume overload, and pH overcorrection resulting
in metabolic alkalosis. Finally, regarding the amount of
bicarbonate needed for correction of metabolic acidosis,
there is no simple formula, because many confounding
factors can affect acid-base status and bicarbonate volume of
distribution. In general, bicarbonate deficit can be calculated
using the equation “HCO3




−) × 0.5 × body weight” [33]. The sodium
bicarbonate amount to be administered should be infused
over hours, rather than as bolus [24, 36, 38, 39]. When
decision to administer bicarbonates has beenmade, clinicians
should monitor for adverse effects, facilitate elimination of
excess CO
2
produced, and correct hypocalcemia, because a
10% reduction of plasma calcium level can depress myocar-
dial contractility and reduce vascular responsiveness to cate-
cholamines [12].
Sodiumbicarbonate increases plasmapH, but this effect is
transient and does not correlate with hemodynamic improve-
ment or improved outcomes in sepsis patients; therefore
addressing the cause remains the most effective therapy for
metabolic acidosis in sepsis. Although acidemia contributes
to cardiovascular dysfunction in sepsis, no controlled study
has demonstrated hemodynamic improvement with bicar-
bonate therapy, regardless of the effect on pH, and studies
have shown worsening of the metabolic and hemodynamic
consequences of acidosis [24, 40]. As there are no docu-
mented benefits from use of sodium bicarbonate in lactic
acidosis related to inadequate tissue perfusion, routine use
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of sodium bicarbonate has been removed from the Advanced
Cardiac Life Support algorithms [40]. In agreement with cur-
rent guidelines, our literature search suggests that although
there is debate regarding sodium bicarbonate use for treat-
ment of lactic acidosis in sepsis, currently available evidence
does not support the use of bicarbonate in sepsis patients with
metabolic acidosis.
5. Conclusions
Routine bicarbonate administration for treatment of lactic
acidosis in sepsis is subject to ongoing debate. Published
evidence suggests that bicarbonate therapy is not beneficial in
cases ofmetabolic acidosis in sepsis andmay even cause harm
by worsening intracellular acidosis. Rational treatment of
metabolic acidosis in sepsis is directed towards addressing the
underlying causes of acidosis and optimizing tissue oxygen
delivery through optimization of cardiopulmonary parame-
ters. However, as recent clinical data from China suggest that
sodium bicarbonate therapy may actually improve outcome
in sepsis patients with acidosis, large, rigorous, well-designed
prospective clinical trials are needed to thoroughly assess the
value of bicarbonate therapy in this patient population.
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